Experimental cancer treatment gives New Jersey mom a chance for a second baby: I decided to go for it foxnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foxnews.com Daily Mail and Mail on Sunday newspapers.
FDA approves pembrolizumab as first-line treatment for colorectal cancer
The FDA recently approved the immunotherapy drug pembrolizumab as a first-line treatment for patients with certain types of advanced colorectal cancer. This is the 9th FDA approval supported by Stand Up To Cancer® (SU2C) research.
Patients newly diagnosed with advanced or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer previously would have been prescribed pembrolizumab only after exhausting standard chemotherapy treatments.
The FDA approved pembrolizumab, also known under the brand name Keytruda, as first-line treatment for metastatic MSI-H dMMR colorectal cancer based on early results from a phase III clinical trial, which was partially funded by an SU2C grant.